Package leaflet: Information for the patient. Eczibet 20 mg/g + 1 mg/g cream (fusidic acid and betamethasone)

Similar documents
Package leaflet: Information for the patient. Xemacort 20 mg/g + 1 mg/g cream (fusidic acid and betamethasone)

Hydrocortisyl Skin Cream 1% Hydrocortisone

1.3.1 PACKAGE LEAFLET: INFORMATION FOR THE USER

Package leaflet: Information for the user

Package leaflet: Information for the user. PRED MILD STERILE OPHTHALMIC SUSPENSION 0.12% w/v Eye Drops, Suspension Prednisolone Acetate

Package leaflet: Information for the patient. Mometasone furoate 0.1%w/w Ointment (mometasone furoate)

Package leaflet: Information for the patient. Histaclar 10 mg Film-coated Tablets loratadine

Package leaflet: Information for the patient. Vertigon 8 mg Tablets Vertigon 16 mg Tablets (betahistine dihydrochloride)

Patient Leaflet : Information for the user Locoid Cream 0.1% w/w Hydrocortisone butyrate

Package leaflet: Information for the user. Relestat, 0.5 mg/ml, eye drops, solution Epinastine hydrochloride

Package leaflet: Information for the user. Fluticrem 0.05% cream Fluticasone propionate

PACKAGE LEAFLET: INFORMATION FOR THE USER Clotrimazole Cream 1%

Package Leaflet: Information for the user. LUMIGAN 0.3 mg/ml, eye drops, solution, in single-dose container Bimatoprost

Proctosedyl Ointment Hydrocortisone/Cinchocaine hydrochloride/framycetin sulphate/aesculin

Package leaflet: Information for the User Clarityn 1 mg/ml syrup Loratadine

PACKAGE LEAFLET: INFORMATION FOR THE USER ACULAR 0.5% w/v EYE DROPS, SOLUTION (Ketorolac trometamol)

Cutivate 0.05% w/w Cream fluticasone propionate

Package leaflet: Information for the user Oftaquix 5 mg/ml eye drops, solution. Levofloxacin

Package leaflet: Information for the User Clarityn 10 mg tablets Loratadine

Package leaflet: information for the user. OZURDEX 700 micrograms intravitreal implant in applicator dexamethasone

Package leaflet: Information for the patient

Package leaflet: Information for the patient. Bumetanide 1 mg and 5 mg Tablets (bumetanide)

Package leaflet: Information for the user. Zoviduo 50 mg/g and 10 mg/g cream. Aciclovir and Hydrocortisone

Betnovate RD (ready diluted) 0.025% w/w Cream betamethasone (as valerate)

Package leaflet: Information for the patient. IKERVIS 1 mg/ml, eye drops, emulsion ciclosporin

Package leaflet: Information for the user. NEVANAC 1 mg/ml eye drops, suspension Nepafenac

Package leaflet: Information for the user. Carmellose sodium

1. WHAT IS CANESTEN HC CREAM AND WHAT IS IT USED FOR?

PRED FORTE 1% w/v Eye Drops, Suspension Prednisolone acetate

Package leaflet: Information for the patient. Calcium Folinate 15 mg Tablets calcium folinate

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT. Monovo 1 mg/g ointment. Mometasone furoate

PACKAGE LEAFLET: INFORMATION FOR THE USER

Package leaflet: Information for the patient UNITED KINGDOM Feldene 5mg/g Gel piroxicam

Package leaflet: Information for the patient. Verkazia 1 mg/ml eye drops emulsion ciclosporin

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT. Beclometasone dipropionate

Package Leaflet - Information for the User. TOBRADEX 3 mg/ml/1 mg/ml Eye Drops, Suspension Tobramycin and Dexamethasone

PACKAGE LEAFLET: INFORMATION FOR THE USER

Package leaflet: Information for the user. Floxapen 250 mg & 500 mg Capsules. Flucloxacillin

PACKAGE LEAFLET 1 April 2017

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT

Package leaflet: Information for the user. Lycimor 300 mg Hard Capsules Lymecycline (equivalent to 300mg of tetracycline base)

Package leaflet: Information for the patient. Olumiant 2 mg film-coated tablets Olumiant 4 mg film-coated tablets Baricitinib

FASTUM 2.5% gel PACKAGE LEAFLET: INFORMATION FOR THE USER. What is in this leaflet? 1. WHAT FASTUM GEL IS AND WHAT IT IS USED FOR

Havrix Monodose Vaccine Hepatitis A Vaccine (Inactivated, adsorbed) ELISA Units/1 ml Suspension for Injection in a pre-filled syringe

Package leaflet: Information for the patient

PACKAGE LEAFLET: INFORMATION FOR THE USER Pulmicort Turbohaler budesonide. 1. What Pulmicort Turbohaler is and what it is used for

Zofran syrup contains a medicine called ondansetron. This belongs to a group of medicines called anti-emetics.

PACKAGE LEAFLET: INFORMATION FOR THE USER. Anastrozole 1 mg film-coated tablets

Package leaflet: Information for the user. Zidoval 7.5 mg/g Vaginal Gel Metronidazole

Package leaflet: Information for the user. Monovo 1 mg/g cutaneous emulsion. mometasone furoate

PATIENT INFORMATION LEAFLET. Naseptin Nasal Cream chlorhexidine dihydrochloride and neomycin sulfate

ANBESOL TM Anaesthetic Antiseptic Oromucosal solution Lidocaine hydrochloride 0.90%w/w, Chlorocresol 0.10%w/w, Cetylpyridinium Chloride 0.

Package leaflet: Information for the user. Catacrom 2 % w/v Eye Drops, Solution. Sodium cromoglicate

Package Leaflet: Information for the user. NEVANAC 3 mg/ml eye drops, suspension nepafenac

PACKAGE LEAFLET: INFORMATION FOR THE USER. NEFOXEF 120 MG FILM-COATED TABLETS NEFOXEF 180 MG FILM-COATED TABLETS Fexofenadine hydrochloride

PACKAGE LEAFLET: INFORMATION FOR THE USER. Pneumococcal Polysaccharide Vaccine

1. What Octostim Nasal Spray is and what it is used for

Package leaflet: Information for the patient Gertac 150 mg and 300 mg. Film-coated Tablets. ranitidine

Package leaflet: Information for the patient. Brimonidine Biogaran 2 mg/ml eye drops, solution. brimonidine tartrate

Package leaflet: Information for the patient LOCABIOTAL Pressurised 125 micrograms Nasal/Oromucosal spray solution Fusafungine

Package leaflet: Information for the patient

PATIENT INFORMATION LEAFLET. PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM LUMIGAN 0,01 %, bimatoprost 0,1 mg/ml eye drops

1 What Flixotide is and what it is used for

PACKAGE LEAFLET: INFORMATION FOR THE USER. Venaforce Varicose Veins gastro-resistant tablets Horse Chestnut seed dry extract

Package leaflet: Information for the user. Levonorgestrel 1.5 mg Tablet. levonorgestrel

PACKAGE LEAFLET Page 1 of 8

Package leaflet: Information for the user. Tuberculin PPD RT23 "SSI" 2 T.U./0.1 ml, solution for injection Tuberculin PPD RT 23

PACKAGE LEAFLET. Page 1 of 6

PACKAGE LEAFLET: INFORMATION FOR THE USER

2 What you need to know before you use Zofran Suppositories

Package leaflet: Information for the user. Ondansetron 4mg/5ml Syrup (ondansetron as ondansetron hydrochloride dihydrate)

Lovastatin tablets 20 and 40 mg PACKAGE LEAFLET

1. What Betahistine dihydrochloride tablets is and what it is used for

Sibelium 5 mg Tablets flunarizine

Package leaflet: Information for the patient. Valotix 500 mg Film-Coated Tablets Valaciclovir

Package leaflet: Information for the patient. IsotrexIN Gel erythromycin 2% and isotretinoin 0.05%

PACKAGE LEAFLET: INFORMATION FOR THE USER. ZADITEN 1 mg/5 ml Oral Solution. Ketotifen (as Ketotifen hydrogen fumarate)

Package leaflet: Information for the patient

Package leaflet: Information for the user. <product name> 3 mg/ml eye drops, solution. Ofloxacin

Dorzolamide 20 mg/ml Eye Drops, Solution

Package leaflet: Information for the patient. Latanoprost 50 micrograms/ml eye drops, solution latanoprost

ANDROGEL 50 mg, gel in sachet Testosterone

PACKAGE LEAFLET: INFORMATION FOR THE USER. GRAZAX 75,000 SQ-T oral lyophilisate

Package leaflet: Information for the user Pulmicort Respules 0.5 mg, Nebuliser Suspension budesonide

Zofran tablets contain a medicine called ondansetron. This belongs to a group of medicines called anti-emetics.

Package leaflet: Information for the user Zinforo 600 mg powder for concentrate for solution for infusion Ceftaroline fosamil

PACKAGE LEAFLET: INFORMATION FOR THE USER. Budesonide Teva 0.5 mg/2 ml Nebuliser Suspension Budesonide

Package leaflet: Information for the patient. Valsartan 320 mg Film-coated Tablets valsartan

1 What Engerix B is and what it is used for

Easyhaler Beclometasone 200 micrograms/dose inhalation powder

Package leaflet: Information for the patient. SIRTURO 100 mg tablets Bedaquiline

Package leaflet: Information for the patient. Flynise 5 mg Orodispersible Tablets desloratadine

PACKAGE LEAFLET: INFORMATION FOR THE USER. Valsartan Mylan 80 mg Film-coated Tablets valsartan

1. What Miacalcic is and what it is used for

PACKAGE LEAFLET: INFORMATION FOR THE USER. DUKORAL suspension and effervescent granules for oral suspension Cholera vaccine (inactivated, oral)

Package Leaflet: Information for the user

Transcription:

Package leaflet: Information for the patient Eczibet 20 mg/g + 1 mg/g cream (fusidic acid and betamethasone) Read all of this leaflet carefully before you start using this medicine because it contains important information for you. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor or pharmacist. This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. In this leaflet Eczibet 20 mg/g + 1 mg/g cream will be called Eczibet. What is in this leaflet: 1. What Eczibet is and what it is used for 2. What you need to know before you use Eczibet 3. How to use Eczibet 4. Possible side effects 5. How to store Eczibet 6. Contents of the pack and other information 1. What Eczibet is and what it is used for Eczibet contains two different types of medicine. One medicine is called fusidic acid. It is a type of antibiotic. The other medicine is called betamethasone. It is a type of corticosteroid (steroid). These two medicines work at the same time in different ways. Eczibet works by: The antibiotic killing germs (bacteria) that cause infections. The corticosteroid reducing any swelling, redness or itchiness of your skin. Eczibet is used to treat: Conditions where the skin is inflamed (eczema or dermatitis) and also infected by germs (bacteria). If there is no improvement after 7 days you should stop using the cream and go back to your doctor. 2. What you need to know before you use Eczibet Do not use Eczibet If you are allergic to fusidic acid or betamethasone or any of the other ingredients in this medicine (listed in Section 6).

To treat infected dermatitis in infants under one year of age. To treat acne vulgaris. To treat a skin condition called acne rosacea. This is redness and inflammation over your nose and cheeks. Ask your doctor if you are unsure. To treat a skin condition called perioral dermatitis. This is a red spotty rash around your mouth or chin. To treat skin conditions caused only by bacteria, such as boils or spots. To treat skin conditions caused by tuberculosis (TB) or syphilis. To treat a skin condition caused by a virus, such as cold sores or chickenpox. To treat a skin condition caused by a fungus, such as athlete s foot or more generalised infections caused by a fungus, e.g. candidiasis. Warnings and precautions Talk to your doctor or pharmacist, before using Eczibet: Do not use the cream on yourself or a child for more than 2 weeks; this is to avoid bacteria becoming resistant to the antibiotic and to avoid the steroid causing you side effects. Take special care if you are going to use this medicine near your eyes or the eyes of a child. If the cream gets into the eye, this may lead to increased pressure in the eye which may cause loss of vision (glaucoma). If you use the cream over a long time or in large amounts it may make the chance of getting any side effects higher. Also your skin may get more sensitive to this medicine. You must not use the medicine for a long time on your face. Unless your doctor has told you to, you must not use Eczibet on open wounds or sensitive areas such as the nostrils, ears, lips or genitals. Unless your doctor has told you to, you must not use Eczibet on thin skin, skin ulcers, broken veins or acne. Your adrenal glands may stop working properly. Signs are tiredness, depression and anxiety. This can be reversed by stopping Eczibet. Other medicines and Eczibet Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. This includes any medicines which you have bought without a prescription. Pregnancy and breast-feeding If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before using this medicine: If you are pregnant, or think you are pregnant: fusidic acid/betamethasone should not be used during pregnancy, unless you are told to do so by your doctor. If you are breast-feeding, fusidic acid/betamethasone may be used by women who are breast-feeding, but the cream should not be applied to the breasts to avoid accidental ingestion by the infant. Tell your doctor if you become pregnant while using this medicine. Driving and using machines Usually your medicine will have very little effect on your ability to drive or use machines. Check with your doctor if you feel any side effect that may stop you from driving or using machines. Eczibet contains cetostearyl alcohol and chlorocresol: Cetostearyl alcohol. May cause local skin reactions (e.g. contact dermatitis). Chlorocresol. May cause allergic reactions.

Please ask your doctor if you are worried about any of the ingredients in this medicine. 3. How to use Eczibet Always use this medicine exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure. How to put on Eczibet This medicine is only for using on your skin or the skin of a child. Do not swallow it. Do not put it inside your body. Remove the cap. Check the seal is not broken before you first use the cream. Then push the spike in the cap through the seal on the tube. Always wash your hands before using Eczibet. Apply thinly to the affected areas. If you use it on your face be careful to avoid your eyes. Unless you are using the cream to treat your hands, always wash your hands after using Eczibet. If you accidentally get any medicine in your eye, wash it out with cold water straight away. Then bathe your eye with eyewash if possible. Your eye may sting. If you start to have any problems with your sight or your eye is sore, contact your doctor immediately. How much Eczibet to use Your doctor will tell you how much Eczibet to use. The usual treatment time is up to two weeks. Ask your doctor before using this medicine for any longer. You should notice your skin improve after just a few days of using the cream. If there is no improvement after 7 days you should stop using the cream and go back to your doctor. Usually you should use this medicine twice each day. Use it in the morning and evening. To remind you to use the medicine it may help to use it when you do another regular action, such as brushing your teeth. If you have been told to cover the skin with any dressings or bandages you may not need to use the medicine so often. A nappy on a baby may act as a dressing. Follow the advice of your doctor. Adults and children: Your doctor should tell you the dose that is right for you or the child. If your doctor has told you the amount of cream to use then keep to this advice. If not, the following guide will help you to use the correct amount. You can use your first (index) finger to measure how much Eczibet to use. Squeeze the cream along your finger from the tip to the first joint. This is called a fingertip unit. The usual number of fingertip units you need to cover different parts of the body is described hereafter. If you need to use a little more or a little less do not worry. If you are using the cream on a child still use an adult finger to measure out the fingertip unit. FOR AN ADULT Site of application Usual number of fingertip units of cream Face and neck 2½ Back of the trunk 7

Front of the trunk 7 One arm (not including the hand) 3 One hand (both sides) 1 One leg (not including the foot)- 6 One foot 2 FOR A CHILD FROM 1 TO 10 YEARS: Usual number of fingertip units of cream Site of application For a child aged 1-2 years For a child aged 3-5 years Face and neck 1½ 1½ 2 One arm and hand 1½ 2 2½ One leg and foot 2 3 4½ Front of the trunk 2 3 3½ Back of the trunk including the buttocks For a child aged 6-10 years 3 3½ 5 If you use more Eczibet than you should Tell your doctor straight away if you have used more Eczibet than you should. You may need to stop using this medicine. If you forget to use Eczibet If you forget to use this medicine, use it as soon as you remember. Then next use this medicine at the usual time. Do not use a double dose to make up for the forgotten dose. If you have any further questions about using this medicine, please ask your doctor or pharmacist. 4. Possible side effects Like all medicines, this medicine can cause side effects, although not everybody gets them. You must get urgent medical help if you have any of the following symptoms. You may be having an allergic reaction: You have difficulty breathing Your face, eyelids, lips, tongue or throat swell Your skin develops a severe rash. Other possible side effects: Any of the problems listed below are more likely if the medicine is used for a long time, in large amounts or on skin folds (such as armpits or under breasts). These problems are more likely in babies and children. They are also more likely if the skin is covered with a dressing, bandage or nappy. Uncommon (may affect up to 1 in 100 people): Itchy rash and skin inflammation in the area where the medicine is used

Burning feeling Itching Worsening of your eczema Dry skin Application site pain Application site irritation Rare (may affect up to 1 in 1,000 people): Hives Skin redness Skin rash Application site swelling Application site blisters Some side effects are known to be caused by betamethasone (steroid), one of the ingredients in Eczibet. You should tell your doctor if any of the side effects occur: Thinning of the skin Stretch marks Small veins near the surface of the skin become visible Changes in growth of your body hair Excessive sweating Red spotty rash around the mouth or chin Lightening of your skin colour Redness of the skin, nose or mouth Loss of vision caused by damage to the optic nerve in the eye, caused by increased pressure in the eye (glaucoma) or by clouding of the lens in the eye (cataract) Adrenal glands may stop working properly. Signs are feeling sick, stomach pain, headache, poor weight gain, lacking energy, tiredness, depression and anxiety. Reporting of side effects If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via HPRA Pharmacovigilance, Earlsfort Terrace, IRL - Dublin 2; Tel: +353 1 6764971; Fax: +353 1 6762517. Website: www.hpra.ie; e-mail: medsafety@hpra.ie. By reporting side effects, you can help provide more information on the safety of this medicine. 5. How to store Eczibet Keep this medicine out of the sight and reach of children. Do not use this medicine after the expiry date which is stated on the carton after EXP. The expiry date is the last day of that month. Do not keep the tube for more than 6 months after you first open it. Make a note of the date you first opened the tube in the space provided on the carton. Do not store the medicine above 30 C.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment. 6. Contents of the pack and other information What Eczibet contains There active substances are two active ingredients, fusidic acid and betamethasone. Eczibet contains 20 mg/g of fusidic acid and 1 mg/g of betamethasone. The other ingredients are macrogol cetostearyl ether, cetostearyl alcohol, chlorocresol (see section 2 Eczibet contains cetostearyl alcohol and chlorocresol, liquid paraffin, sodium dihydrogen phosphate dihydrate, white soft paraffin, all-rac-α-tocopherol, purified water and sodium hydroxide. What Eczibet looks like and contents of the pack Eczibet is a white to off-white smooth cream in an aluminium tube, with a white polypropylene screw cap. Eczibet comes in tubes of 5g; 15g; 30g and 60g. Not all pack sizes may be marketed. Marketing Authorisation Holder Generics [UK] Limited Station Close, Potters Bar, Hertfordshire EN6 1TL, United Kingdom Manufacturer McDermott Laboratories Ltd. T/A Gerard Laboratories, 35/36 Baldoyle Industrial Estate, Grange Road, Dublin 13, Ireland. Mylan Hungary Kft., Mylan utca 1, Komárom 2900, Hungary. This medicinal product is authorized in Member States of the EEA under the following names: Belgium: Acide fusidique / bétaméthasone valérate Goapharma 20 mg/g / 1 mg/g crème Denmark: Fusidinsyre / Betamethasonevalerat Mylan 20 mg/g / 1 mg/g Creme Germany: Fusidinsäure/ Betamethason Mylan 20 mg/g + 1 mg/g Creme Greece: Fusidic acid/ Betamethasone valerate / Mylan 20 mg/g + 1 mg/g Cream Ireland: Eczibet 20 mg/g + 1 mg/g cream Italy: Acido fusidico e Betametasone Mylan Portugal: Betametasona / Ácido fusídico Mylan 1 mg/g + 20 mg/g Creme Spain: Ácido fusídico/betametasona valerato Mylan 20 mg/g + 1 mg/g Crema United Kingdom: Xemacort 20 mg/g and 1 mg/g cream This leaflet was last revised in 09/2016